Loading...

Christine H Holschneider

Title(s)Professor of Clinical , Obstetrics and Gynecology
SchoolMedicine
Phone(747) 210-3222
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Park SK, Holschneider CH, Chen J, Saleeby E, Singhal R. Success of an EMR-Driven Postpartum Intervention to Improve HPV Vaccination Rates. J Community Health. 2020 Jun; 45(3):446-451. PMID: 31659600.
      View in: PubMed
    2. Kim CH, Lefkowits C, Holschneider C, Bixel K, Pothuri B. Managing opioid use in the acute surgical setting: A society of gynecologic oncology clinical practice statement. Gynecol Oncol. 2020 Feb 24. PMID: 32107049.
      View in: PubMed
    3. Liang MI, Prendergast EN, Staples JN, Holschneider CH, Cohen JG, Cass I. Prognostic role of pathologic response and cytoreductive status at interval debulking surgery after neoadjuvant chemotherapy for advanced epithelial ovarian cancer. J Surg Oncol. 2019 Sep; 120(4):779-785. PMID: 31283034.
      View in: PubMed
    4. Strom EM, Chaudhry ZQ, Guo R, Maisonet AJ, Holschneider CH, Wieslander CK. Effectiveness of Assessing Ureteral Patency Using Preoperative Phenazopyridine. Female Pelvic Med Reconstr Surg. 2019 Jul/Aug; 25(4):289-293. PMID: 29300258.
      View in: PubMed
    5. Holschneider CH, Petereit DG, Chu C, Hsu IC, Ioffe YJ, Klopp AH, Pothuri B, Chen LM, Yashar C. Brachytherapy: A critical component of primary radiation therapy for cervical cancer: From the Society of Gynecologic Oncology (SGO) and the American Brachytherapy Society (ABS). Brachytherapy. 2019 Mar - Apr; 18(2):123-132. PMID: 30665713.
      View in: PubMed
    6. Holschneider CH, Petereit DG, Chu C, Hsu IC, Ioffe YJ, Klopp AH, Pothuri B, Chen LM, Yashar C. Brachytherapy: A critical component of primary radiation therapy for cervical cancer: From the Society of Gynecologic Oncology (SGO) and the American Brachytherapy Society (ABS). Gynecol Oncol. 2019 03; 152(3):540-547. PMID: 30665615.
      View in: PubMed
    7. Satmary W, Holschneider CH, Brunette LL, Natarajan S. Vulvar intraepithelial neoplasia: Risk factors for recurrence. Gynecol Oncol. 2018 01; 148(1):126-131. PMID: 29126556.
      View in: PubMed
    8. Cormano J, Mackay G, Holschneider C. Gestational Trophoblastic Disease Diagnosis Delayed by the Hook Effect. Obstet Gynecol. 2015 Oct; 126(4):811-4. PMID: 26132453.
      View in: PubMed
    9. MacQueen IT, Dawes AJ, Hadnott T, Strength K, Moran GJ, Holschneider C, Russell MM, Maggard-Gibbons M. Use of a Hospital-Wide Screening Program for Early Detection of Sepsis in General Surgery Patients. Am Surg. 2015 Oct; 81(10):1074-9. PMID: 26463311.
      View in: PubMed
    10. Beavis AL, Cheema S, Holschneider CH, Duffy EL, Amneus MW. Almost half of women with endometrial cancer or hyperplasia do not know that obesity affects their cancer risk. Gynecol Oncol Rep. 2015 Aug; 13:71-5. PMID: 26425728.
      View in: PubMed
    11. Saleeby E, Holschneider CH, Singhal R. Paradigm shifts: using a participatory leadership process to redesign health systems. Curr Opin Obstet Gynecol. 2014 Dec; 26(6):516-22. PMID: 25310529.
      View in: PubMed
    12. Diaz ES, Aoyama C, Baquing MA, Beavis A, Silva E, Holschneider C, Cass I. Predictors of residual carcinoma or carcinoma-in-situ at hysterectomy following cervical conization with positive margins. Gynecol Oncol. 2014 Jan; 132(1):76-80. PMID: 24262876.
      View in: PubMed
    13. Beavis A, Amneus M, Aoyama C, Holschneider CH. Tattoo pigment lymphadenopathy mimicking metastasis in vulvar cancer. Obstet Gynecol. 2012 Aug; 120(2 Pt 2):442-4. PMID: 22825260.
      View in: PubMed
    14. Penner KR, Dorigo O, Aoyama C, Ostrzega N, Balzer BL, Rao J, Walsh CS, Cass I, Holschneider CH. Predictors of resolution of complex atypical hyperplasia or grade 1 endometrial adenocarcinoma in premenopausal women treated with progestin therapy. Gynecol Oncol. 2012 Mar; 124(3):542-8. PMID: 22079678.
      View in: PubMed
    15. Salani R, Backes FJ, Fung MF, Holschneider CH, Parker LP, Bristow RE, Goff BA. Posttreatment surveillance and diagnosis of recurrence in women with gynecologic malignancies: Society of Gynecologic Oncologists recommendations. Am J Obstet Gynecol. 2011 Jun; 204(6):466-78. PMID: 21752752.
      View in: PubMed
    16. Aletti GD, Eisenhauer EL, Santillan A, Axtell A, Aletti G, Holschneider C, Chi DS, Bristow RE, Cliby WA. Identification of patient groups at highest risk from traditional approach to ovarian cancer treatment. Gynecol Oncol. 2011 Jan; 120(1):23-8. PMID: 20933255.
      View in: PubMed
    17. Singhal R, Rubenstein LV, Wang M, Lee ML, Raza A, Holschneider CH. Variations in practice guideline adherence for abnormal cervical cytology in a county healthcare system. J Gen Intern Med. 2008 May; 23(5):575-80. PMID: 18286344.
      View in: PubMed
    18. Salani R, Axtell A, Gerardi M, Holschneider C, Bristow RE. Limited utility of conventional criteria for predicting unresectable disease in patients with advanced stage epithelial ovarian cancer. Gynecol Oncol. 2008 Feb; 108(2):271-5. PMID: 18164380.
      View in: PubMed
    19. Karam A, Feldman N, Holschneider CH. Neoadjuvant cisplatin and radical cesarean hysterectomy for cervical cancer in pregnancy. Nat Clin Pract Oncol. 2007 Jun; 4(6):375-80. PMID: 17534393.
      View in: PubMed
    20. Axtell AE, Lee MH, Bristow RE, Dowdy SC, Cliby WA, Raman S, Weaver JP, Gabbay M, Ngo M, Lentz S, Cass I, Li AJ, Karlan BY, Holschneider CH. Multi-institutional reciprocal validation study of computed tomography predictors of suboptimal primary cytoreduction in patients with advanced ovarian cancer. J Clin Oncol. 2007 Feb 01; 25(4):384-9. PMID: 17264334.
      View in: PubMed
    21. Cass I, Holschneider C, Datta N, Barbuto D, Walts AE, Karlan BY. BRCA-mutation-associated fallopian tube carcinoma: a distinct clinical phenotype? Obstet Gynecol. 2005 Dec; 106(6):1327-34. PMID: 16319259.
      View in: PubMed
    22. Wang J, Wieslander C, Hansen G, Cass I, Vasilev S, Holschneider CH. Thin endometrial echo complex on ultrasound does not reliably exclude type 2 endometrial cancers. Gynecol Oncol. 2006 Apr; 101(1):120-5. PMID: 16307792.
      View in: PubMed
    23. Walsh C, Holschneider C, Hoang Y, Tieu K, Karlan B, Cass I. Coexisting ovarian malignancy in young women with endometrial cancer. Obstet Gynecol. 2005 Oct; 106(4):693-9. PMID: 16199623.
      View in: PubMed
    24. Holschneider CH, Baldwin RL, Tumber K, Aoyama C, Karlan BY. The fragile histidine triad gene: a molecular link between cigarette smoking and cervical cancer. Clin Cancer Res. 2005 Aug 15; 11(16):5756-63. PMID: 16115913.
      View in: PubMed
    25. Aoyama C, Liu P, Ostrzega N, Holschneider CH. Histologic and immunohistochemical characteristics of neoplastic and nonneoplastic subgroups of atypical squamous lesions of the uterine cervix. Am J Clin Pathol. 2005 May; 123(5):699-706. PMID: 15981809.
      View in: PubMed
    26. Elkas JC, Holschneider CH, Katz B, Li AJ, Louie R, McGonigle KF, Berek JS. The use of continuous infusion topotecan in persistent and recurrent ovarian cancer. Int J Gynecol Cancer. 2003 Mar-Apr; 13(2):138-41. PMID: 12657113.
      View in: PubMed
    27. Memarzadeh S, Holschneider CH, Bristow RE, Jones NL, Fu YS, Karlan BY, Berek JS, Farias-Eisner R. FIGO stage III and IV uterine papillary serous carcinoma: impact of residual disease on survival. Int J Gynecol Cancer. 2002 Sep-Oct; 12(5):454-8. PMID: 12366662.
      View in: PubMed
    28. Holschneider CH, Berek JS. Ovarian cancer: epidemiology, biology, and prognostic factors. Semin Surg Oncol. 2000 Jul-Aug; 19(1):3-10. PMID: 10883018.
      View in: PubMed
    29. Holschneider CH, Felix JC, Satmary W, Johnson MT, Sandweiss LM, Montz FJ. A single-visit cervical carcinoma prevention program offered at an inner city church: A pilot project. Cancer. 1999 Dec 15; 86(12):2659-67. PMID: 10594861.
      View in: PubMed
    30. Holschneider CH, Ghosh K, Montz FJ. See-and-treat in the management of high-grade squamous intraepithelial lesions of the cervix: a resource utilization analysis. Obstet Gynecol. 1999 Sep; 94(3):377-85. PMID: 10472863.
      View in: PubMed
    31. Holschneider CH, Nejad F, Montz FJ. Immunomodulation with interleukin-10 and interleukin-4 compared with ketorolac tromethamine for prevention of postoperative adhesions in a murine model. Fertil Steril. 1999 Jan; 71(1):67-73. PMID: 9935118.
      View in: PubMed
    32. Holschneider CH, Cristoforoni PM, Ghosh K, Punyasavatsut M, Abed E, Montz FJ. Endogenous versus exogenous IL-10 in postoperative intraperitoneal adhesion formation in a murine model. J Surg Res. 1997 Jul 01; 70(2):138-43. PMID: 9245562.
      View in: PubMed
    33. Kim YB, Holschneider CH, Ghosh K, Nieberg RK, Montz FJ. Progestin alone as primary treatment of endometrial carcinoma in premenopausal women. Report of seven cases and review of the literature. Cancer. 1997 Jan 15; 79(2):320-7. PMID: 9010105.
      View in: PubMed
    34. Montz FJ, Holschneider CH, Munro MG. Incisional hernia following laparoscopy: a survey of the American Association of Gynecologic Laparoscopists. Obstet Gynecol. 1994 Nov; 84(5):881-4. PMID: 7936531.
      View in: PubMed
    35. Montz FJ, Holschneider CH, Bozuk M, Gotlieb WH, Martinez-Maza O. Interleukin 10: ability to minimize postoperative intraperitoneal adhesion formation in a murine model. Fertil Steril. 1994 Jun; 61(6):1136-40. PMID: 8194630.
      View in: PubMed
    36. Holschneider CH, Solh S, Lebherz TB, Montz FJ. The modified Pereyra procedure in recurrent stress urinary incontinence: a 15-year review. Obstet Gynecol. 1994 Apr; 83(4):573-8. PMID: 8134068.
      View in: PubMed
    37. Montz FJ, Holschneider CH, Solh S, Schuricht LC, Monk BJ. Small bowel obstruction following radical hysterectomy: risk factors, incidence, and operative findings. Gynecol Oncol. 1994 Apr; 53(1):114-20. PMID: 8175009.
      View in: PubMed
    38. Holschneider CH, Johnson MT, Knox RM, Rezai A, Ryan WJ, Montz FJ. Bullatacin--in vivo and in vitro experience in an ovarian cancer model. Cancer Chemother Pharmacol. 1994; 34(2):166-70. PMID: 8194168.
      View in: PubMed
    39. Montz FJ, Holschneider CH, Thompson LD. Large-loop excision of the transformation zone: effect on the pathologic interpretation of resection margins. Obstet Gynecol. 1993 Jun; 81(6):976-82. PMID: 8497366.
      View in: PubMed